Aytu BioScience, Inc.

Aytu BioScience, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Aytu BioScience, Inc. is not a good growth stock. Aytu BioScience, Inc. is not very popular among insiders. Aytu BioScience, Inc. is a mediocre stock to choose.
Log in to see more information.
Aytu BioScience, Inc. is a specialty pharmaceutical company, which engages in the development and co...
AYTU Fundamental Data by TradingView

News

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Accesswire DENVER, CO / ACCESSWIRE / August 8, 2024 / Aytu BioPharma, Inc. (the 'Company' or 'Aytu') (Nasdaq: AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that...\n more…

Aytu Biopharma announces sale of consumer health business
Aytu Biopharma announces sale of consumer health business

SeekingAlpha.com: All News Aytu BioPharma sells its Consumer Health business to a private e-commerce company, with revenue-based royalty payments on future sales.\n more…

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Accesswire Consumer Health Wind Down and Sale Maximizes Shareholder Value as Company Focuses on Rx SegmentEliminates Materially All Remaining Expenses Associated with the Consumer Health BusinessProvides for...\n more…

It's Probably Less Likely That Aytu BioPharma, Inc.'s (NASDAQ:AYTU) CEO Will See A Huge Pay Rise This Year
It's Probably Less Likely That Aytu BioPharma, Inc.'s (NASDAQ:AYTU) CEO Will See A Huge Pay Rise This Year

Simply Wall St Key Insights Aytu BioPharma will host its Annual General Meeting on 26th of June Salary of US$590.0k is part of CEO...\n more…

Aytu Biopharma announces paydown and refinancing of term loan
Aytu Biopharma announces paydown and refinancing of term loan

Seeking Alpha - Healthcare Aytu Biopharma announces paydown and refinancing of term loan...\n more…

Aytu BioScience Bolsters Growth with Strategic Financial Moves
Aytu BioScience Bolsters Growth with Strategic Financial Moves

TipRanks Financial Blog Aytu BioScience (AYTU) has provided an update. Aytu BioPharma has recently enhanced its financial flexibility through a major funding move. The company secured a $1...\n more…